Diabetes Screening Interventions in Low- and Middle- Income Countries: A Systematic Review
This systematic review of 19 studies across 12 low- and middle-income countries characterizes heterogeneous type 2 diabetes screening interventions, identifying task-shifting and integration into existing health systems as key facilitators while highlighting critical gaps in care linkage, follow-up, and economic evidence that necessitate future programs to prioritize at-risk populations and embed comprehensive linkage-to-care strategies.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
In many parts of the world, a silent health crisis is unfolding. Type 2 diabetes, a condition where the body struggles to manage sugar in the blood, is becoming increasingly common in low- and middle-income countries. These are nations where resources for healthcare are often stretched thin, and the systems designed to keep people healthy are fragile. A defining feature of this crisis is that so many people do not know they are sick. The disease can develop slowly over years without causing obvious symptoms, meaning a person might live with it for a long time before they feel unwell. By the time symptoms appear, serious damage to the heart, kidneys, and eyes may have already occurred. Finding these hidden cases early through screening—checking people who feel fine to see if they have the disease—is seen as a vital way to prevent suffering and save lives. However, in places with limited money and staff, it is not always clear how to run these screening programs effectively, or how to ensure that once a person is found to be sick, they actually receive the treatment they need.
Researchers at the University of Sheffield set out to map the landscape of these screening efforts. They gathered and analyzed nineteen different studies conducted across twelve countries, looking at how diabetes screening was actually carried out in real-world settings. Their goal was not just to see if the tests worked, but to understand the entire process: who was being tested, where it happened, who did the testing, and what happened to the people after they were screened. They found that the approaches varied widely. Some programs tested everyone in a community, while others focused only on people who were at higher risk, such as those with a family history of the disease or those already being treated for tuberculosis. The most successful programs in terms of finding new cases were the ones that targeted these specific high-risk groups rather than trying to screen the entire population indiscriminately.
The location and the people doing the work also mattered significantly. Many of the most effective programs took place outside of traditional hospitals, bringing the screening directly to people in their homes, at community centers, or even at places of worship. This approach helped reach people who might otherwise never visit a clinic due to cost or distance. A key finding was the successful use of community health workers—local residents who are trained to perform basic health tasks. In several studies, these workers, rather than doctors, were the ones conducting the tests and explaining the results. This strategy, known as task-shifting, allowed the programs to reach more people without needing a large number of expensive medical specialists. The use of simple tools, like portable blood sugar meters and digital apps on tablets, also helped make the process smoother and more reliable.
However, the study revealed a significant gap between finding the disease and curing it. While many programs were good at identifying people with diabetes, the chain of care often broke down immediately after the diagnosis. The researchers found that only three of the nineteen studies managed to follow a person all the way from the initial test to receiving ongoing treatment and monitoring. In most cases, people who tested positive were referred to a clinic, but a large number of them never showed up for their follow-up appointments. This loss of patients happened for several reasons: some did not feel sick enough to seek further help, others could not afford the cost of treatment, or the health system simply did not have a clear plan to keep them connected to care. The studies also highlighted that very little information was available about the actual costs of these programs, making it difficult for governments to plan sustainable solutions.
The researchers concluded that while screening for diabetes in resource-limited settings is possible and can be done successfully, the current methods are often incomplete. The most promising path forward involves integrating screening into existing health services, such as tuberculosis or HIV clinics, and focusing efforts on the people most likely to be sick. Crucially, future programs must be designed with the entire journey in mind, ensuring that a person who is found to have diabetes is not just told they are sick, but is actively guided through the steps to get treatment and stay healthy. Without this full connection, the effort to find the disease risks being wasted, leaving the most vulnerable populations without the care they desperately need.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.